Health and Healthcare

Biogen : BIIB

All Biogen Articles

606 Articles

cgblaine22 | Jan 29, 2014 at 12:10 PM EST

Why Caution Is Prevailing in Biotechs Into and After Earnings

Biogen Idec surprised investors Wednesday with weaker-than-expected guidance for 2014 earnings. Amgen beat estimates late Tuesday. Celgene and Gilead Sciences…

Trey Thoelcke | Jan 29, 2014 at 8:50 AM EST

The Best of the Best Picks of the Credit Suisse Top 50 Stocks

Frank Golhen, via Wikimedia CommonsMost of the firms that we cover on Wall Street have presented their high conviction stock…

Jon C. Ogg | Jan 27, 2014 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Cisco, Lululemon, Nokia, Peabody, Xerox and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Monday, January 27, 2014.…

Trey Thoelcke | Jan 22, 2014 at 9:05 AM EST

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside

Here are some of the top biotech names to buy at Cowen. They presented such an extensive list that we…

Trey Thoelcke | Jan 9, 2014 at 8:15 AM EST

Credit Suisse Favors Quality at Any Price Top Momentum Growth Stocks

In a new research report, the investment strategy team at Credit Suisse is recommending investors look to move out of…

Lee Jackson | Dec 14, 2013 at 8:01 AM EST

Five Big Analyst Stock Picks for 2014

As 2013 begins to wind down, 24/7 Wall St. has started to scan our coverage of Wall Street firms for…

Lee Jackson | Dec 11, 2013 at 9:00 AM EST

Credit Suisse Offers Top Biotech Stocks to Buy for 2014

ThinkstockCredit Suisse is out and pounding the table that biotechnology cannot be ignored in 2014. Biotech has been the top-performing…

Lee Jackson | Nov 6, 2013 at 8:30 AM EST

UBS Sees Hedge Funds Selling Health Care and Buying Financial and Energy Stocks

ThinkstockThe UBS proprietary institutional flow data indicates that hedge funds are increasing exposure to financials and decreasing exposure to health…

Lee Jackson | Oct 24, 2013 at 9:00 AM EDT

Merrill Lynch Top America’s Edge Stocks to Buy and Sell for the Fourth Quarter

courtesy of AOL, IncHeading into the fourth quarter of this year, investors who have been long the stock market are…

Trey Thoelcke | Oct 14, 2013 at 8:15 AM EDT

Jefferies Top Biotech Stocks to Buy

ThinkstockThe world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not…

Jon C. Ogg | Oct 2, 2013 at 8:35 AM EDT

Top Analyst Upgrades and Downgrades: Alcoa, Baidu, GE, Tesla, Valero and More

Jon OggInvestors and traders alike are looking for ideas and recommendations now that the government shutdown is here and with…

Jon C. Ogg | Sep 18, 2013 at 8:40 AM EDT

Top Analyst Upgrades and Stocks to Buy: AT&T, Nokia, Lululemon and More

Investors and traders are worried about an end to quantitative easing, yet stocks are rallying hard on fundamentals. This puts…

Lee Jackson | Sep 16, 2013 at 8:45 AM EDT

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the…

Jon C. Ogg | Jul 1, 2013 at 8:25 AM EDT

Top 10 Analyst Upgrades and Downgrades: Apple, BlackBerry, 3M and More

These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Monday, July 1, 2013.…

Jon C. Ogg | Jul 1, 2013 at 8:20 AM EDT

Top Biotech Stocks to Buy and Stocks to Short From PropThink

ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug…

1 … 28 29 30 31 32 … 41

Biogen : BIIB

All Biogen Articles

Why Caution Is Prevailing in Biotechs Into and After Earnings

The Best of the Best Picks of the Credit Suisse Top 50 Stocks

Top Analyst Upgrades and Downgrades: Cisco, Lululemon, Nokia, Peabody, Xerox and More

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside

Credit Suisse Favors Quality at Any Price Top Momentum Growth Stocks

Five Big Analyst Stock Picks for 2014

Credit Suisse Offers Top Biotech Stocks to Buy for 2014

UBS Sees Hedge Funds Selling Health Care and Buying Financial and Energy Stocks

Merrill Lynch Top America’s Edge Stocks to Buy and Sell for the Fourth Quarter

Jefferies Top Biotech Stocks to Buy

Top Analyst Upgrades and Downgrades: Alcoa, Baidu, GE, Tesla, Valero and More

Top Analyst Upgrades and Stocks to Buy: AT&T, Nokia, Lululemon and More

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Top 10 Analyst Upgrades and Downgrades: Apple, BlackBerry, 3M and More

Top Biotech Stocks to Buy and Stocks to Short From PropThink

Google Losing Top AI Executive Is ‘The Most Significant AI Talent Move of the Year.’ Is It Time to Sell Alphabet Stock?

How Much Can a 62-Year-Old Couple With $2.3 Million in Their 401(k) Save With Roth Conversions?

Widow’s Two-Year Tax Window on Home Sale Could Save $250,000 in Capital Gains

How Much Can a 62-Year-Old Couple With $2.3 Million in Their 401(k) Save With Roth Conversions?

Widow's Two-Year Tax Window on Home Sale Could Save $250,000 in Capital Gains

Google Losing Top AI Executive Is ‘The Most Significant AI Talent Move of the Year.’ Is It Time to Sell Alphabet Stock?

How Much Can a 62-Year-Old Couple With $2.3 Million in Their 401(k) Save With Roth Conversions?

Biogen : BIIB

All Biogen Articles

Why Caution Is Prevailing in Biotechs Into and After Earnings

The Best of the Best Picks of the Credit Suisse Top 50 Stocks

Top Analyst Upgrades and Downgrades: Cisco, Lululemon, Nokia, Peabody, Xerox and More

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside

Credit Suisse Favors Quality at Any Price Top Momentum Growth Stocks

Five Big Analyst Stock Picks for 2014

Credit Suisse Offers Top Biotech Stocks to Buy for 2014

UBS Sees Hedge Funds Selling Health Care and Buying Financial and Energy Stocks

Merrill Lynch Top America’s Edge Stocks to Buy and Sell for the Fourth Quarter

Jefferies Top Biotech Stocks to Buy

Top Analyst Upgrades and Downgrades: Alcoa, Baidu, GE, Tesla, Valero and More

Top Analyst Upgrades and Stocks to Buy: AT&T, Nokia, Lululemon and More

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Top 10 Analyst Upgrades and Downgrades: Apple, BlackBerry, 3M and More

Top Biotech Stocks to Buy and Stocks to Short From PropThink

Google Losing Top AI Executive Is ‘The Most Significant AI Talent Move of the Year.’ Is It Time to Sell Alphabet Stock?

How Much Can a 62-Year-Old Couple With $2.3 Million in Their 401(k) Save With Roth Conversions?

Widow’s Two-Year Tax Window on Home Sale Could Save $250,000 in Capital Gains

Featured Reads

How Much Can a 62-Year-Old Couple With $2.3 Million in Their 401(k) Save With Roth Conversions?

Widow's Two-Year Tax Window on Home Sale Could Save $250,000 in Capital Gains